Literature DB >> 15102917

Corticotropin-releasing factor and Urocortin I modulate excitatory glutamatergic synaptic transmission.

Jie Liu1, Baojian Yu, Volker Neugebauer, Dimitri E Grigoriadis, Jean Rivier, Wylie W Vale, Patricia Shinnick-Gallagher, Joel P Gallagher.   

Abstract

Corticotropin-releasing factor (CRF)-related peptides serve as hormones and neuromodulators of the stress response and play a role in affective disorders. These peptides are known to alter complex behaviors and neuronal properties, but their receptor-mediated effects at CNS synapses are not well described. Here we show that excitatory glutamatergic transmission is modulated by two endogenous CRF-related peptide ligands, corticotropin-releasing factor [CRF rat/human (r/h)] and Urocortin I (Ucn I), within the central nucleus of the amygdala (CeA) and the lateral septum mediolateral nucleus (LSMLN). These limbic nuclei are reciprocally innervated, are involved in stress and affective disorders, and have high densities of the CRF receptors CRF1 and CRF2. Activation of these receptors exerts diametrically opposed actions on glutamatergic transmission in these nuclei. In the CeA, CRF(r/h) depressed excitatory glutamatergic transmission through a CRF1-mediated postsynaptic action, whereas Ucn I facilitated synaptic responses through presynaptic and postsynaptic CRF2-mediated mechanisms. Conversely, in the LSMLN, CRF caused a CRF1-mediated facilitation of glutamatergic transmission via postsynaptic mechanisms, whereas Ucn I depressed EPSCs by postsynaptic and presynaptic CRF2-mediated actions. Furthermore, antagonists of these receptors also affected glutamatergic neurotransmission, indicating that endogenous ligands tonically modulated synoptic activity at these synapses. These data show that CRF receptors in CeA and LSMLN synapses exert and maintain a significant synaptic tone and thereby regulate excitatory glutamatergic transmission. The results also suggest that CRF receptors may provide novel targets in affective disorders and stress.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15102917      PMCID: PMC6729414          DOI: 10.1523/JNEUROSCI.5531-03.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  55 in total

1.  Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.

Authors:  John C Umhau; Reza Momenan; Melanie L Schwandt; Erick Singley; Mariel Lifshitz; Linda Doty; Lauren J Adams; Valentina Vengeliene; Rainer Spanagel; Yan Zhang; Jun Shen; David T George; Daniel Hommer; Markus Heilig
Journal:  Arch Gen Psychiatry       Date:  2010-10

2.  Central infusion of ovine CRF (oCRF) potentiates defensive behaviors in CD-1 mice in the Mouse Defense Test Battery (MDTB).

Authors:  Mu Yang; Catherine Farrokhi; Amy Vasconcellos; Robert J Blanchard; D Caroline Blanchard
Journal:  Behav Brain Res       Date:  2006-04-18       Impact factor: 3.332

3.  Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats.

Authors:  Cindy K Funk; Eric P Zorrilla; Mei-Jing Lee; Kenner C Rice; George F Koob
Journal:  Biol Psychiatry       Date:  2006-07-28       Impact factor: 13.382

Review 4.  Role of corticotropin releasing factor in anxiety disorders: a translational research perspective.

Authors:  Victoria B Risbrough; Murray B Stein
Journal:  Horm Behav       Date:  2006-07-25       Impact factor: 3.587

5.  Cellular and molecular mechanisms of hippocampal activation by acute stress are age-dependent.

Authors:  Y Chen; K A Fenoglio; C M Dubé; D E Grigoriadis; T Z Baram
Journal:  Mol Psychiatry       Date:  2006-06-27       Impact factor: 15.992

6.  Glutamatergic transmission in the central nucleus of the amygdala is selectively altered in Marchigian Sardinian alcohol-preferring rats: Alcohol and CRF effects.

Authors:  Melissa A Herman; Florence P Varodayan; Christopher S Oleata; George Luu; Dean Kirson; Markus Heilig; Roberto Ciccocioppo; Marisa Roberto
Journal:  Neuropharmacology       Date:  2015-10-28       Impact factor: 5.250

7.  Enhanced GABAergic transmission in the central nucleus of the amygdala of genetically selected Marchigian Sardinian rats: alcohol and CRF effects.

Authors:  Melissa A Herman; Marsida Kallupi; George Luu; Christopher S Oleata; Markus Heilig; George F Koob; Roberto Ciccocioppo; Marisa Roberto
Journal:  Neuropharmacology       Date:  2012-12-04       Impact factor: 5.250

8.  Type 1 corticotropin-releasing factor receptor expression reported in BAC transgenic mice: implications for reconciling ligand-receptor mismatch in the central corticotropin-releasing factor system.

Authors:  Nicholas J Justice; Zung Fan Yuan; Paul E Sawchenko; Wylie Vale
Journal:  J Comp Neurol       Date:  2008-12-01       Impact factor: 3.215

9.  Corticotropin-releasing factor in the mouse central nucleus of the amygdala: ultrastructural distribution in NMDA-NR1 receptor subunit expressing neurons as well as projection neurons to the bed nucleus of the stria terminalis.

Authors:  Marc A Beckerman; Tracey A Van Kempen; Nicholas J Justice; Teresa A Milner; Michael J Glass
Journal:  Exp Neurol       Date:  2012-10-12       Impact factor: 5.330

Review 10.  Synaptic physiology of central CRH system.

Authors:  Joel P Gallagher; Luis F Orozco-Cabal; Jie Liu; Patricia Shinnick-Gallagher
Journal:  Eur J Pharmacol       Date:  2008-02-01       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.